ロード中...
CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3
Despite significant progress in cancer therapy over the last decades, ovarian cancer remains the most lethal gynecologic malignancy worldwide with the five-year overall survival rate less than 30% due to frequent disease recurrence and chemoresistance. CD44 is a non-kinase transmembrane receptor tha...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7736609/ https://ncbi.nlm.nih.gov/pubmed/33335857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.589601 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|